CFO
WST icon

CVA Family Office’s West Pharmaceutical WST Stock Holding History

CVA Family Office’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.6K Buy
269
+12
+5% +$3.67K 0.01% 476
2026
Q1 		$64.4K Buy
257
+40
+18% +$9.95K 0.01% 545
2025
Q4 		$59.7K Sell
217
-2
-0.9% -$547 0.01% 528
2025
Q3 		$57.5K Buy
219
+17
+8% +$4.13K 0.01% 528
2025
Q2 		$44.2K Buy
202
+172
+573% +$36.8K 0.01% 566
2025
Q1 		$6.72K Sell
30
-36
-55% -$9.92K ﹤0.01% 861
2024
Q4 		$21.6K Buy
66
+54
+450% +$17K ﹤0.01% 662
2024
Q3 		$3.6K Sell
12
-12
-50% -$3.67K ﹤0.01% 893
2024
Q2 		$7.91K Buy
24
+3
+14% +$1.06K ﹤0.01% 772
2024
Q1 		$8.31K Buy
21
+1
+5% +$370 ﹤0.01% 768
2023
Q4 		$7.04K Buy
+20
New +$7.08K ﹤0.01% 772
2023
Q3 		– Sell
-25
Closed -$9.56K – 964
2023
Q2 		$9.56K Buy
25
+5
+25% +$1.79K ﹤0.01% 727
2023
Q1 		$6.93K Buy
+20
New +$5.84K ﹤0.01% 734
2022
Q4 		– Sell
-45
Closed -$11K – 1015
2022
Q3 		$11K Sell
45
-25
-36% -$7.62K ﹤0.01% 618
2022
Q2 		$21K Buy
70
+25
+56% +$8.13K 0.01% 535
2022
Q1 		$18K Hold
45
– – ﹤0.01% 589
2021
Q4 		$21K Buy
+45
New +$19.4K 0.01% 522
2021
Q3 		– Sell
-63
Closed -$23K – 896
2021
Q2 		$23K Buy
63
+18
+40% +$5.95K 0.01% 506
2021
Q1 		$13K Buy
+45
New +$12.9K ﹤0.01% 493

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

CVA Family Office's WST Position: Q2 2026 in Review

CVA Family Office increased its West Pharmaceutical (WST) stake by 4.7% in Q2 2026, buying an estimated $3.67K and bringing the position to 269 shares worth $96.6K. The position accounts for 0.01% of the portfolio, ranked #476.

CVA Family Office first reported a position in WST in Q1 2021 and has held it in 19 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • CVA Family Office held 269 shares of West Pharmaceutical worth $96.6K as of Q2 2026.
  • CVA Family Office bought 12 West Pharmaceutical shares in Q2 2026, an estimated $3.67K.
  • West Pharmaceutical made up 0.01% of CVA Family Office's portfolio in Q2 2026, its #476 holding.
  • CVA Family Office first reported a position in West Pharmaceutical in Q1 2021 and has held it in 19 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.